• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    MicroRNAs as mediators of resistance mechanisms to small-molecule tyrosine kinase inhibitors in solid tumours.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Ghidini, M
    Hahne, J
    Frizziero, Melissa
    Tomasello, G
    Trevisani, F
    Lampis, A
    Passalacqua, R
    Valeri, N
    Affiliation
    Medical Department, Division of Oncology, ASST di Cremona, Ospedale di Cremona, Cremona, Italy
    Issue Date
    2018-08
    
    Metadata
    Show full item record
    Abstract
    Receptor tyrosine kinases (RTKs) are widely expressed transmembrane proteins that act as receptors for growth factors and other extracellular signalling molecules. Upon ligand binding, RTKs activate intracellular signalling cascades, and as such are involved in a broad variety of cellular functions including differentiation, proliferation, migration, invasion, angiogenesis, and survival under physiological as well as pathological conditions. Aberrant RTK activation can lead to benign proliferative conditions as well as to various forms of cancer. Indeed, more than 70% of the known oncogene and proto-oncogene transcripts involved in cancer code for RTKs. Consequently, these receptors are broadly studied as targets in the treatment of different tumours, and a large variety of small-molecule tyrosine kinase inhibitors (TKIs) are approved for therapy. In most cases, patients develop resistance to the TKIs within a short time. MicroRNAs are short (18-22 nucleotides) non-protein-coding RNAs that fine-tune cell homeostasis by controlling gene expression at the post-transcriptional level. Deregulation of microRNAs is common in many cancers, and increasing evidence exists for an important role of microRNAs in the development of resistance to therapies, including TKIs. In this review we focus on the role of microRNAs in mediating resistance to small-molecule TKIs in solid tumours.
    Citation
    MicroRNAs as mediators of resistance mechanisms to small-molecule tyrosine kinase inhibitors in solid tumours. 2018, 13(4): 423-436 Target Oncol
    Journal
    Targeted Oncology
    URI
    http://hdl.handle.net/10541/621241
    DOI
    10.1007/s11523-018-0580-3
    PubMed ID
    30006826
    Type
    Article
    Language
    en
    ISSN
    1776-260X
    ae974a485f413a2113503eed53cd6c53
    10.1007/s11523-018-0580-3
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies.
    • Authors: Hojjat-Farsangi M
    • Issue date: 2014 Aug 8
    • Small tyrosine kinase inhibitors as key molecules in the expression of metalloproteinases by solid tumors.
    • Authors: Stahtea XN, Kousidou OCh, Roussidis AE, Tzanakakis GN, Karamanos NK
    • Issue date: 2008
    • MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer.
    • Authors: Donzelli S, Cioce M, Muti P, Strano S, Yarden Y, Blandino G
    • Issue date: 2016 Feb
    • Targeting the MET gene for the treatment of non-small-cell lung cancer.
    • Authors: Gelsomino F, Facchinetti F, Haspinger ER, Garassino MC, Trusolino L, De Braud F, Tiseo M
    • Issue date: 2014 Feb
    • Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls.
    • Authors: Tolmachev V, Stone-Elander S, Orlova A
    • Issue date: 2010 Oct
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.